Each member company has an employee who is designated its official Delegate. The delegate participates in any official election or organizational vote and would represent the member company in any matter of law or issues regarding the association’s governance or bylaws. Member company delegates are normally CEO’s, presidents, vice presidents of sales, procurement or sourcing or those who have industry experience and knowledge of other member companies and colleagues. (Marketing, administrative and customer service professionals should not be considered a delegate from their member company.)
Because DCAT’s membership is corporate, each employee of a registered member company is entitled and encouraged to participate in the DCAT organization and receive information and any other benefits provided by the organization.
Elected by their peers, the Board of Directors has the authority and responsibility for the governance of the organization. Its members serve as thought leaders who develop and guide the organization’s strategic plan, establish and implement policy, and manage financial matters in a manner to best serve member companies.
Appointed by the president of the organization, committee chairpersons are responsible to lead the committee and provide oversight of projects that involve and serve the member companies.
Elected by their peers, the Advisory Council consists of representatives from various segments of the industry to provide insights, guidance and expertise to the Board of Directors, committees, task forces and staff to best serve member companies.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.